NO20002972D0 - N-benzyl-3-indenylacetamidderivater for behandling av neoplasi - Google Patents
N-benzyl-3-indenylacetamidderivater for behandling av neoplasiInfo
- Publication number
- NO20002972D0 NO20002972D0 NO20002972A NO20002972A NO20002972D0 NO 20002972 D0 NO20002972 D0 NO 20002972D0 NO 20002972 A NO20002972 A NO 20002972A NO 20002972 A NO20002972 A NO 20002972A NO 20002972 D0 NO20002972 D0 NO 20002972D0
- Authority
- NO
- Norway
- Prior art keywords
- benzyl
- treatment
- neoplasia
- acetamide derivatives
- indenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/989,353 US5948779A (en) | 1997-12-12 | 1997-12-12 | Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes |
| US09/206,245 US6066634A (en) | 1997-12-12 | 1998-12-07 | Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia |
| PCT/GB1998/003712 WO1999031065A1 (en) | 1997-12-12 | 1998-12-11 | N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20002972D0 true NO20002972D0 (no) | 2000-06-09 |
| NO20002972L NO20002972L (no) | 2000-08-09 |
| NO317097B1 NO317097B1 (no) | 2004-08-09 |
Family
ID=26901185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002972A NO317097B1 (no) | 1997-12-12 | 2000-06-09 | N-benzyl-3-indenylacetamidderivater for behandling av neoplasi |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US6166053A (no) |
| EP (1) | EP1044187B1 (no) |
| JP (1) | JP4307719B2 (no) |
| CN (1) | CN100436418C (no) |
| AT (1) | ATE257152T1 (no) |
| AU (1) | AU752072B2 (no) |
| BR (1) | BR9813540A (no) |
| CA (1) | CA2314339C (no) |
| CZ (1) | CZ298826B6 (no) |
| DE (1) | DE69820908T2 (no) |
| ES (1) | ES2212383T3 (no) |
| HU (1) | HU227153B1 (no) |
| IL (1) | IL136603A0 (no) |
| NO (1) | NO317097B1 (no) |
| NZ (1) | NZ504958A (no) |
| PL (1) | PL196936B1 (no) |
| TR (1) | TR200001687T2 (no) |
| WO (1) | WO1999031065A1 (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200001687T2 (tr) * | 1997-12-12 | 2000-10-23 | Cell Pathways, Inc. | Neopleasyo için N-benzil-3-indenilasetamid türevleri. |
| IL132366A0 (en) * | 1998-10-15 | 2001-03-19 | Cell Pathways Inc | Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds |
| EP1278522B1 (en) * | 2000-04-19 | 2006-10-25 | Lilly Icos LLC | Pde-v inhibitors for treatment of parkinson's disease |
| DE10058663A1 (de) * | 2000-11-25 | 2002-05-29 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| WO2002067936A1 (en) * | 2001-02-21 | 2002-09-06 | Cell Pathways, Inc. | Methods for treatment of inflammatory bowel disease |
| DE10135815A1 (de) * | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| US20030073711A1 (en) * | 2001-08-23 | 2003-04-17 | Whitehead Clark M. | Methods for treatment of scleroderma |
| US20030073740A1 (en) * | 2001-08-23 | 2003-04-17 | Whitehead Clark M. | Methods for treatment of lupus erythematosus |
| US6479493B1 (en) * | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
| CN100398522C (zh) * | 2003-08-20 | 2008-07-02 | Irm责任有限公司 | 组织蛋白酶s的抑制剂 |
| US6995622B2 (en) * | 2004-01-09 | 2006-02-07 | Robert Bosh Gmbh | Frequency and/or phase compensated microelectromechanical oscillator |
| CA2568906C (en) | 2004-06-02 | 2010-09-21 | Merit Diamond Corporation | Comfort interior for jewelry and jewelry including that interior |
| CN1332930C (zh) * | 2005-08-05 | 2007-08-22 | 中国科学院上海有机化学研究所 | 制备乙氰菊酯前体的方法 |
| NZ569430A (en) * | 2006-01-04 | 2012-05-25 | Southern Res Inst | Derivatives of sulindac, use thereof and preparation thereof |
| WO2009022756A1 (ja) * | 2007-08-13 | 2009-02-19 | Katayama Chemical Industries Co., Ltd. | 虚血性疾患の診断及び治療 |
| WO2010053910A1 (en) * | 2008-11-04 | 2010-05-14 | Wellstat Therapeutics Corporation | Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids |
| EP2462001A4 (en) | 2009-08-07 | 2017-07-12 | Auckland UniServices Limited | Roadway powered electric vehicle system |
| US20160168108A1 (en) | 2014-12-16 | 2016-06-16 | Adt Pharmaceuticals, Inc. | Method of treating or preventing ras-mediated diseases |
| US9862698B2 (en) | 2014-12-16 | 2018-01-09 | Adt Pharmaceuticals, Inc. | Indenyl compounds, pharmaceutical compositions, and medical uses thereof |
| EP3784228A1 (en) | 2018-04-26 | 2021-03-03 | ADT Pharmaceuticals, LLC | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0508586B1 (en) * | 1991-03-08 | 1995-05-31 | Fgn, Inc. | Substituted indenyl compounds |
| US6063818A (en) * | 1996-06-13 | 2000-05-16 | Cell Pathways Inc. | Substituted benzylidene indenyl formamides, acetamides and propionamides |
| TR200001687T2 (tr) * | 1997-12-12 | 2000-10-23 | Cell Pathways, Inc. | Neopleasyo için N-benzil-3-indenilasetamid türevleri. |
| US5948779A (en) * | 1997-12-12 | 1999-09-07 | Cell Pathways, Inc. | Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes |
-
1998
- 1998-12-11 TR TR2000/01687T patent/TR200001687T2/xx unknown
- 1998-12-11 BR BR9813540-6A patent/BR9813540A/pt not_active Application Discontinuation
- 1998-12-11 DE DE69820908T patent/DE69820908T2/de not_active Expired - Lifetime
- 1998-12-11 AU AU14981/99A patent/AU752072B2/en not_active Ceased
- 1998-12-11 NZ NZ504958A patent/NZ504958A/xx unknown
- 1998-12-11 EP EP98959050A patent/EP1044187B1/en not_active Expired - Lifetime
- 1998-12-11 PL PL341151A patent/PL196936B1/pl not_active IP Right Cessation
- 1998-12-11 WO PCT/GB1998/003712 patent/WO1999031065A1/en active IP Right Grant
- 1998-12-11 HU HU0100170A patent/HU227153B1/hu not_active IP Right Cessation
- 1998-12-11 CZ CZ20002157A patent/CZ298826B6/cs not_active IP Right Cessation
- 1998-12-11 CN CNB988118955A patent/CN100436418C/zh not_active Expired - Fee Related
- 1998-12-11 IL IL13660398A patent/IL136603A0/xx active IP Right Grant
- 1998-12-11 JP JP2000538992A patent/JP4307719B2/ja not_active Expired - Fee Related
- 1998-12-11 CA CA002314339A patent/CA2314339C/en not_active Expired - Fee Related
- 1998-12-11 ES ES98959050T patent/ES2212383T3/es not_active Expired - Lifetime
- 1998-12-11 AT AT98959050T patent/ATE257152T1/de not_active IP Right Cessation
-
2000
- 2000-01-24 US US09/490,269 patent/US6166053A/en not_active Expired - Lifetime
- 2000-06-09 NO NO20002972A patent/NO317097B1/no not_active IP Right Cessation
- 2000-12-20 US US09/741,970 patent/US6426349B1/en not_active Expired - Fee Related
-
2002
- 2002-07-26 US US10/206,687 patent/US6610854B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1281436A (zh) | 2001-01-24 |
| HUP0100170A1 (hu) | 2001-07-30 |
| DE69820908D1 (de) | 2004-02-05 |
| CZ20002157A3 (cs) | 2000-10-11 |
| JP2002508358A (ja) | 2002-03-19 |
| BR9813540A (pt) | 2000-10-10 |
| NO20002972L (no) | 2000-08-09 |
| JP4307719B2 (ja) | 2009-08-05 |
| AU752072B2 (en) | 2002-09-05 |
| HUP0100170A3 (en) | 2001-12-28 |
| EP1044187A1 (en) | 2000-10-18 |
| PL341151A1 (en) | 2001-03-26 |
| HU227153B1 (en) | 2010-08-30 |
| CA2314339A1 (en) | 1999-06-24 |
| AU1498199A (en) | 1999-07-05 |
| ES2212383T3 (es) | 2004-07-16 |
| NO317097B1 (no) | 2004-08-09 |
| DE69820908T2 (de) | 2004-12-23 |
| US20030009033A1 (en) | 2003-01-09 |
| US6426349B1 (en) | 2002-07-30 |
| IL136603A0 (en) | 2001-06-14 |
| NZ504958A (en) | 2003-03-28 |
| CA2314339C (en) | 2009-09-08 |
| WO1999031065A1 (en) | 1999-06-24 |
| PL196936B1 (pl) | 2008-02-29 |
| CN100436418C (zh) | 2008-11-26 |
| CZ298826B6 (cs) | 2008-02-20 |
| TR200001687T2 (tr) | 2000-10-23 |
| EP1044187B1 (en) | 2004-01-02 |
| US6610854B2 (en) | 2003-08-26 |
| US6166053A (en) | 2000-12-26 |
| ATE257152T1 (de) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002972D0 (no) | N-benzyl-3-indenylacetamidderivater for behandling av neoplasi | |
| HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
| DE69329321D1 (de) | Produkt mit hohen Pullulangehalt, dessen Herstellung und Verwendung | |
| ATE109002T1 (de) | Wasserlösliche antineoplastische taxolderivate. | |
| HUP0102563A3 (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| DE69712296T2 (de) | DERIVATE DES PYRAZOLO-(1,5-a)-PYRIMIDINE, DESSEN HERSTELLUNG UND HAARFÄRBEMITTEL MIT SOLCHEN DERIVATEN | |
| ATE514676T1 (de) | Ionisierbare indolinon derivate und deren verwendung als ptk liganden | |
| TR199901361T2 (xx) | S�lfonamid t�revleri, haz�rlanma prosesi ve ila� olarak kullan�mlar� | |
| AR023777A1 (es) | Nuevos compuestos | |
| FI972484A0 (fi) | Karsinooman hoito | |
| AU9312198A (en) | Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer | |
| EE03858B1 (et) | Konjugaadid, nende kasutamine eesnäärmevähi ravimites, farmatseutiline kompositsioon ja selle valmistamine | |
| BR9709720A (pt) | Formamidas, acetamidas e propionamidas indezil benzilideno substituìdas | |
| ATE285733T1 (de) | Rehabilitationsgerät | |
| DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
| ES2187799T3 (es) | Complejos de bis-platino con derivados de polimetileno como ligandos que tienen actividad antitumoral. | |
| EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
| IT1298376B1 (it) | Trattamento di reticolazione e sterilizzazione per la produzione di manufatti in polietilene ad elevate caratteristiche tribologiche, | |
| HK1079116A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
| DE68910893D1 (de) | Alkenyltetrazole Derivate, ihre Herstellung und ihre Verwendung. | |
| FI964672A0 (fi) | Viljankäsittelymenetelmä, käsitelty vilja ja sen käyttö | |
| RU96100171A (ru) | Способ сушки корешков книжных блоков | |
| ES1021720Y (es) | Dispositivo para la correcion local de la densidad del producto prensado en prensas ceramicas y similares. | |
| FI991173A0 (fi) | Menetelmä syöpäriskin detektoimiseksi ja testipakkaus sitä varten | |
| ECSP992841A (es) | Nuevos derivados del acido dihidroxihexanoico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |